CBZ stock forecast, quote, news & analysis
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide... Show more
Why CBIZ, Inc. (CBZ) Is Up +24% in the Last 30 Days
Key Takeaways
- CBZ stock surged +24% over the past 30 days, driven primarily by a strong Q1 2026 earnings beat and raised full-year guidance.
- Over the past quarter, shares declined -18%, reflecting earlier weakness from Q4 2025 results, soft organic growth, and integration challenges from acquisitions.
- Key catalysts included client delays in Q4 billings, key personnel departures, and analyst concerns over growth sustainability.
- Recent recovery highlights improving sentiment amid raised EPS outlook and deleveraging efforts.
- Investors should monitor organic revenue trends and M&A (mergers and acquisitions) integration for future price movement.
CBIZ, Inc. (CBZ) Company Overview and Market Position
CBIZ, Inc. (CBZ) is a leading provider of financial, insurance, and advisory services across the United States and Canada. The company operates through three main segments: Financial Services, Benefits and Insurance Services, and Risk and Advisory Services. Its core business model revolves around delivering integrated professional services to middle-market businesses, including accounting, tax planning, employee benefits consulting, property and casualty insurance brokerage, and risk management solutions.
In the competitive professional services industry, CBIZ holds a strong position through its national footprint, acquired expertise, and client-centric approach. Recent aggressive M&A activity has expanded its scale, boosting revenue but also introducing integration costs and debt levels. These fundamentals explain recent stock behavior, as investors weigh topline growth against margin pressures and organic performance.
CBIZ, Inc. (CBZ) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, CBZ stock rose +24%, climbing from approximately $26.85 to $33.17. The movement was volatile but trend-driven, with a steady rebound from mid-March lows accelerating in late April following earnings.
In contrast, the past quarter saw a -18% decline, dropping from around $40.59 to $33.17. This period featured a sharp early plunge to a 52-week low near $24.29, followed by a partial recovery, characterized by high volatility amid negative news flow.
What Drove CBZ Stock Price in the Last 30 Days
The +24% gain in CBZ's stock price over the past 30 days was propelled by positive Q1 2026 earnings released on April 29. The company reported adjusted EPS of $2.63, surpassing estimates of $2.22, despite a slight revenue miss at $848.6 million versus expectations of $852 million. Management raised full-year adjusted EPS guidance to $4.00-$4.10 and EBITDA outlook, signaling confidence in recovery.
This beat countered prior concerns, sparking a post-earnings surge of over 2% on April 29. Broader market sentiment shifted positively as shares rebounded from oversold levels near $25, with reduced selling pressure and institutional interest supporting the uptrend. Sector tailwinds in professional services also aided the climb.
What Drove CBZ Stock Performance Over the Last Quarter
CBZ shares fell -18% over the quarter due to sustained negative catalysts, starting with Q4 2025 earnings on February 25. Results showed a revenue miss and adjusted EPS of -$0.70 versus estimates of -$0.66, blamed on clients deferring work into 2026 and acquisition integration costs impacting productivity.
Organic growth disappointed, masked by acquisitive revenue gains, leading to outlook questions. An unexpected producer team departure in February exacerbated declines. Analyst actions included price target cuts and downgrades, with concerns over high debt from M&A and modest 2026 revenue guidance of 2-5% growth. Macro pressures like tighter credit and selective dealmaking in private equity advisory further weighed on sentiment, driving the stock to a March low before partial stabilization.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI-powered trading bots from a library of hundreds scanning thousands of tickers. These curated bots employ diverse strategies, such as trend-following, mean reversion, or momentum plays, across various timeframes from intraday to long-term. Performance metrics like win rate, profit factor, and drawdown are highlighted, helping traders identify relevant tools for stocks like CBZ. Updated in real-time, the section filters for consistency and relevance amid market trends. Explore these bots to enhance your stock analysis and automate trading decisions.
CBZ Stock Forecast Drivers: What Investors Should Watch Next
Investors should track CBIZ's organic revenue growth and M&A integration progress, as these will clarify sustainability beyond acquisition-driven expansion. Upcoming Q2 2026 earnings will provide updates on EPS execution against raised guidance and free cash flow generation for deleveraging.
Key industry trends like private equity activity and insurance market dynamics could influence advisory demand. Macro factors, including interest rates and economic slowdown risks, may impact client spending. Potential catalysts include further share repurchases or strategic deals, while risks involve talent retention and margin recovery.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Momentum Indicator for CBZ turns positive, indicating new upward trend
CBZ saw its Momentum Indicator move above the 0 level on May 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CBZ just turned positive on May 21, 2026. Looking at past instances where CBZ's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
CBZ moved above its 50-day moving average on May 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CBZ advanced for three days, in of 341 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 266 cases where CBZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for CBZ moved out of overbought territory on June 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CBZ broke above its upper Bollinger Band on June 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CBZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.961) is normal, around the industry mean (16.059). P/E Ratio (13.310) is within average values for comparable stocks, (73.392). CBZ's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.558). CBZ has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.022). P/S Ratio (0.767) is also within normal values, averaging (8.648).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of financial and employee benefits services
Industry OfficeEquipmentSupplies